tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GKOS Stock Latest News

Glaukos Reports Record Sales Despite Net Loss
Company AnnouncementsGlaukos Reports Record Sales Despite Net Loss
1m ago
8K
GKOS
Notable companies reporting after market close
PremiumThe Fly
Notable companies reporting after market close
3h ago
MQ
ST
Glaukos Corp. (GKOS) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Glaukos Corp. (GKOS) Q3 Earnings Cheat Sheet
3d ago
GKOS
Glaukos says Epioxa Phase 3 confirmatory trial meets primary endpoint
PremiumThe Fly
Glaukos says Epioxa Phase 3 confirmatory trial meets primary endpoint
19d ago
GKOS
Glaukos, Ripple Therapeutics enter licensing agreement
PremiumThe Fly
Glaukos, Ripple Therapeutics enter licensing agreement
20d ago
GKOS
Glaukos price target raised to $152 from $145 at Truist
PremiumThe FlyGlaukos price target raised to $152 from $145 at Truist
21d ago
GKOS
Glaukos price target raised to $145 from $130 at Stifel
Premium
The Fly
Glaukos price target raised to $145 from $130 at Stifel
2M ago
GKOS
Glaukos price target raised to $139 from $131 at BTIG
Premium
The Fly
Glaukos price target raised to $139 from $131 at BTIG
2M ago
GKOS
Glaukos to Present Investor Insights in Upcoming Sessions
PremiumCompany Announcements
Glaukos to Present Investor Insights in Upcoming Sessions
3M ago
8K
GKOS
Glaukos raises FY24 revenue view to $370M-$376M from $357M-$365M
PremiumThe Fly
Glaukos raises FY24 revenue view to $370M-$376M from $357M-$365M
3M ago
GKOS
Glaukos reports Q2 adjusted EPS (52c), consensus (51c)
PremiumThe Fly
Glaukos reports Q2 adjusted EPS (52c), consensus (51c)
3M ago
GKOS
Glaukos Q2 Financial Performance and Business Overview
PremiumCompany Announcements
Glaukos Q2 Financial Performance and Business Overview
3M ago
8K
GKOS
Is GKOS a Buy, Before Earnings?
PremiumPre-EarningsIs GKOS a Buy, Before Earnings?
3M ago
GKOS
Glaukos price target raised to $141 from $125 at Truist
Premium
The Fly
Glaukos price target raised to $141 from $125 at Truist
4M ago
GKOS
Glaukos price target raised to $120 from $100 at Morgan Stanley
Premium
The Fly
Glaukos price target raised to $120 from $100 at Morgan Stanley
4M ago
GKOS
Glaukos price target raised to $131 from $112 at BTIG
PremiumThe Fly
Glaukos price target raised to $131 from $112 at BTIG
4M ago
GKOS
Glaukos downgraded to Neutral from Buy at Citi
PremiumThe Fly
Glaukos downgraded to Neutral from Buy at Citi
4M ago
GKOS
Glaukos Governance and Compensation Strategy Evolves
PremiumCompany Announcements
Glaukos Governance and Compensation Strategy Evolves
5M ago
8K
GKOS
Glaukos price target raised to $130 from $110 at Stifel
PremiumThe Fly
Glaukos price target raised to $130 from $110 at Stifel
5M ago
GKOS
Glaukos price target raised to $120 from $110 at Wells Fargo
PremiumThe FlyGlaukos price target raised to $120 from $110 at Wells Fargo
5M ago
GKOS
Glaukos price target raised to $130 from $120 at Citi
Premium
The Fly
Glaukos price target raised to $130 from $120 at Citi
6M ago
GKOS
Micron upgraded, Peloton downgraded: Wall Street’s top analyst calls
Premium
The Fly
Micron upgraded, Peloton downgraded: Wall Street’s top analyst calls
6M ago
X
EH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >